Alivus Life Sciences Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Nirma Limited, was filed 12 Mar 2024.
Alivus Life Sciences Limited: what insiders have been doing
This page follows insider dealings at Alivus Life Sciences Limited as filed with SEBI (PIT + SAST), a company from the Health Care sector. Alivus Life Sciences Limited has had no insider filing for more than a year; the last one goes back to 15 July 2024.
For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Analyst consensus: bullish or bearish?
Analysts rate Alivus Life Sciences Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹1,245.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 9,609,571 shares@ ₹830.734335.2% of flowEquity SharesSEBI:2c31a04572c81e5986c1ab15a86149561a79c127
- 7,800 shares@ ₹829.625154.6% of flowEquity SharesSEBI:8571841e409214e686dc31c1e3d5ec7c00fab77a
- 24,505,435 shares@ ₹597.993764.8% of flowEquity SharesSEBI:e50275fe84a87e25976ef64aa45f049062faa22b
- 24,505,435 shares@ ₹598.5923100.0% of flowEquity SharesSEBI:8f6d214ad6b87762efce05e5290938c8dc4c4fd9Canonical exit: 10 Jun 2024 (T+90)
- 67,389,944 shares@ ₹597.993887.0% of flowEquity SharesSEBI:7a6580285e4ab87778892b1e6940df5b0906ece1
- 9,609,571 shares@ ₹615.0013.0% of flowEquity SharesSEBI:a028b009998f2b6cd0e9f0078c26b6d97e983bed
- 295 shares@ ₹640.76611.7% of flowEquity SharesSEBI:a844d425e971878fa72024c1c608c4095f1c4b27Canonical exit: 13 Feb 2022 (T+90)
- 7,505 shares@ ₹643.187743.7% of flowEquity SharesSEBI:fedd2ab7716e5bbf7ff3bd5029db25fa1e9c7990Canonical exit: 14 Feb 2022 (T+90)
8 of 8 declarations
About Alivus Life Sciences Limited
Alivus Life Sciences Limited is a company focused on the health and pharmaceutical sector. It is listed on the XBOM.
